` BRA (Braster SA) vs WIG20 Comparison - Alpha Spread

B
BRA
vs
W
WIG20

Over the past 12 months, BRA has underperformed WIG20, delivering a return of 0% compared to the WIG20's +29% growth.

Stocks Performance
BRA vs WIG20

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BRA vs WIG20

Performance Gap Between BRA and WIG20
HIDDEN
Show

Performance By Year
BRA vs WIG20

Loading
BRA
WIG20
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Braster SA vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Braster SA
Glance View

Market Cap
17m PLN
Industry
Health Care

Braster SA engages in the development and manufacturing of medical devices for self-examination. The firm provides research and development on breast cancer. The company applies liquid crystals and liquid crystal emulsion formula that is used to produce liquid crystal matrix based on LCD technology, continuous film CLCF (Continuous Liquid Crystal Film) in the diagnosis of breast cancer. Its main product is Braster Tester, which is a device that uses thermographic liquid crystal matrices for diagnosing breast cancer; the device is made up of three film matrices covered with a liquid crystal mixture that allows thermal imaging. The firm cooperates with the Jagiellonian University, with the participation of the clinical trial conducted by Thermacrac, among others.

BRA Intrinsic Value
Not Available
Back to Top